Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Laparoscopic Cholecystectomy vs. Non-operative Treatment for Gallbladder Dyskinesia
NCT02195115Phase 2Unknown
- Sponsor
- CAMC Health System
- Start
- Feb 2014
- Primary completion
- Jul 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of amitriptyline in biliary dyskinesia (BD) (2 arms), sponsored by CAMC Health System. Primary endpoint: SF-8 Quality of Life Questionnaire at 18 months. Status: unknown.
02
Drugs
amitriptyline
03
Conditions
biliary dyskinesia (BD)
Beyond the preview
Go deeper on NCT02195115.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02195115.